RMEI Medical Education, LLC and Postgraduate Institute for Medicine:
Sunday, March 26th
11:00-12:30 - Les Goudes 1
Industry sponsored and supported symposia
Jazz Pharmaceuticals:
Sunday, March 26th
15:00-16:30 - Endoume 1+2
A Nurse's Role in the Management of Acute Transplant Complications
Monday, March 27th
12:45-14:15 - Hall 2
The Changing Picture of Transplant Complications: Real-life Examples
Tuesday, March 28th
13:00-14:00 - Les Goudes 2
Basilea:
Sunday, March 26th
15:00-16:30 - Auditorium
Insights and opportunities in IMD and haematological malignancies
Tuesday, March 28th
16:30-17:30 - Les Goudes 2
Pfizer:
Sunday, March 26th
11:00-12:30 - Hall 1
Advances in the management of aplastic anaemia: An interactive symposium
Sunday, March 26th
13:00-14:30 - Hall 1
Targeted approaches to improve outcomes in AML
Sunday, March 26th
17:00-18:45 - Les Goudes 2
Takeda:
Sunday, March 26th
15:00-16:30 - Hall 1
The pivotal role of proteasome inhibition in myeloma treatment
Tuesday, March 28th
12:45-14:15 - Hall 2
Time for change: Improving outcomes in CD30-positive lymphomas
Amgen:
Sunday, March 26th
13:00-14:30 - Les Goudes 1
Stem cell transplantation in multiple myeloma – Strategies and potential
Sunday, March 26th
15:00-16:30 - Les Goudes 1
Celgene:
Sunday, March 26th
17:00-18:00 - Amphithéâtre Callelongue
60 Minutes to Revisit Allo-Transplant in HR MDS and AML
Sunday, March 26th
18:00-19:00 - Amphithéâtre Callelongue
CAR-T Cell therapy: Today and tomorrow
Monday, March 27th
16:30-18:00 - Hall 2
How Can We Raise the Bar in the Management of Transplant-Eligible Multiple Myeloma Patients?
Sanofi-Genzyme:
Sunday, March 26th
11:00-13:00 - Amphithéâtre Callelongue
Sunday, March 26th
14:30-16:30 - Amphithéâtre Callelongue
Miltenyi Biotec:
Sunday, March 26th
13:00-15:00 - Les Goudes 2
Molmed:
Sunday, March 26th
11:00-12:30 - Hall 2
Tuesday, March 28th
12:45-14:15 - Hall 1
Mallinckrodt Pharmaceuticals (Therakos (UK) Ltd.):
Sunday, March 26th
17:00-19:00 - Les Goudes 1
Monday, March 27th
12:45-14:15 - Hall 1
Therakos Integrated Photopheresis: Value for Nurses and Patients through Education
Janssen:
Sunday, March 26th
17:00-19:00 - Endoume 1+2+3
Novel agents in hematological malignancies: joining forces with transplantation?
Oxford Immunotec:
Sunday, March 26th
13:00-14:30 - Hall 2
Insights on New Developments in CMV Immune Monitoring and Alternative Therapies for HSCT Recipients
Kiadis:
Sunday, March 26th
11:00-12:30 - Les Goudes 2
Advances in haploidentical stem cell transplantation and post-transplant immunotherapy
MSD:
Sunday, March 26th
09:00-10:30 - Auditorium
CMV infection in your hematology patient – what's standard, what's new?
Sunday, March 26th
11:00-12:30 - Auditorium
Fungal Infections in Transplant Recipients: Managing the Continuum of Risk
Sunday, March 26th
17:00-18:30 - Auditorium
A Novel Approach to prevent Recurrent C difficile Infections (CDI) in High Risk Patients